NiXEN and Fremman have partnered to execute a leveraged buyout of Palex, a leading MedTech solutions provider based in Spain, to support its international expansion and growth initiatives.
Information on the Target
Founded in 1955 and headquartered in Barcelona, Palex stands as the leading independent provider of MedTech solutions in Southern Europe. The company specializes in the marketing, sales, and logistics of high-value MedTech products for both public and private hospitals and laboratories in Spain, Portugal, and Italy. Palex is renowned for its commitment to innovation, quality, and customer service, boasting a comprehensive portfolio that includes over 150,000 product references sourced from more than 600 leading global manufacturers.
Palex's strategic focus on high-value MedTech solutions positions it uniquely within the healthcare market, allowing it to cater to the evolving needs of healthcare providers. With a proven track record and strong industry partnerships, the company is poised for significant growth within its sectors.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Spain
The MedTech industry in Spain has been witnessing considerable growth, driven by technological advancements and an increasing demand for healthcare services. As the Spanish population ages, the necessity for ad
Similar Deals
Management Team of Ortopedia Sumisan, S.L. → Ortopedia Sumisan, S.L.
2025
Ortopedia Sumisan, S.L. → Ortopedia Sumisan, S.L.
2025
Miura Partners → HTBA
2024
Abac Capital and Pronokal's management team → Pronokal
2023
NiXEN
invested in
Palex
in 2024
in a Management Buyout / Buy-In (MBO) deal